Register by May 15 to Save up to $550 off the standard rates.
» View Pricing
Printed from the IBC Life Sciences Web site on April 26, 2015 11:41 AM ET.
Page location: http://www.ibclifesciences.com/CellTherapy/overview.xml
Industry Job Functions:
Designed for Director to C-Level professionals from the following departments:
Get up-to-date with the global industrial biotherapeutic community from BioProcess International™ Magazine
Recognizing the need to devote more time to properly cover the incredible amount of progress being made in this field, we have expanded the format to included in-depth tracks on bioprocessing, technologies, commercialization, gene therapy, tissue engineering and biofabrication, and regulatory considerations. In addition, we have added a two-day track devoted to the tremendous progress of cancer immunotherapies through clinical trials, which will focus on novel targets, combinations, and commercialization considerations that will help advance immunotherapies from discovery to launch.
"The best commercial manufacturing conference in cell therapy to date. Period!" - Lee Buckler, Cell Therapy Group
"The first conference that combined classical bioprocessing tech and industry with academic and clinical fields." - Ricardo Baptista, University of Toronto
With an unparalleled reputation for delivering the technical and process innovations to help companies build the bridge from proof of concept to commercialization, this year's Cell Therapy Bioprocessing & Commercialization event offers the perfect experience for process scientists and engineers who are challenged with developing scalable manufacturing processes. We have developed a conference that balances data-driven content, technical demonstrations and networking that helps companies accelerate their cell therapy programs through cost-effective and efficient approaches that will help them achieve the ultimate goal of commercialization.